🏢CompaniesRoche Secures Two FDA Approvals for Oncology and Immunology Treatments
Swiss pharmaceutical giant Roche Holdings saw its shares slip 0.70% to $60.52 following the green light from regulators for new therapies targeting breast cancer and chro…